| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.29 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |